$CATX
Perspective Therapeutics Inc

2022 Q2 Form 10-Q Financial Statement

#000143774922012202 Filed on May 13, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $2.505M $2.910M $2.816M
YoY Change -7.56% 11.92% 19.37%
Cost Of Revenue $1.579M $1.469M $1.596M
YoY Change 15.76% 18.66% 33.89%
Gross Profit $926.0K $1.441M $1.220M
YoY Change -31.2% 5.8% 4.54%
Gross Profit Margin 36.97% 49.52% 43.32%
Selling, General & Admin $2.236M $2.268M $2.320M
YoY Change 13.44% 28.57% 32.72%
% of Gross Profit 241.47% 157.39% 190.16%
Research & Development $796.0K $549.0K $535.0K
YoY Change 70.09% 51.66% 87.72%
% of Gross Profit 85.96% 38.1% 43.85%
Depreciation & Amortization $75.00K $74.00K $71.00K
YoY Change 47.06% 64.44% 54.35%
% of Gross Profit 8.1% 5.14% 5.82%
Operating Expenses $3.032M $2.817M $2.855M
YoY Change 24.31% 32.38% 39.95%
Operating Profit -$2.106M -$1.376M -$1.635M
YoY Change 92.68% 79.63% 87.29%
Interest Expense $28.00K $29.00K $31.00K
YoY Change -12.5% 38.1% 520.0%
% of Operating Profit
Other Income/Expense, Net $28.00K $29.00K $31.00K
YoY Change 38.1% 520.0%
Pretax Income -$2.078M -$1.347M -$1.604M
YoY Change 95.85% 80.81% 84.79%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.078M -$1.347M -$1.604M
YoY Change 95.85% 80.81% 84.79%
Net Earnings / Revenue -82.95% -46.29% -56.96%
Basic Earnings Per Share -$0.01 -$0.01 -$0.01
Diluted Earnings Per Share -$14.63K -$9.483K -$11.30K
COMMON SHARES
Basic Shares Outstanding 142.0M 142.0M 141.9M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.89M $58.90M $60.35M
YoY Change -12.44% -9.16% 529.67%
Cash & Equivalents $55.89M $58.90M $60.35M
Short-Term Investments
Other Short-Term Assets $27.00K $551.0K $535.0K
YoY Change 0.0% 14.08% 77.74%
Inventory $1.396M $1.163M $1.068M
Prepaid Expenses
Receivables $1.608M $2.140M $1.647M
Other Receivables $17.00K $0.00 $0.00
Total Short-Term Assets $59.33M $62.76M $63.60M
YoY Change -11.85% -7.81% 417.57%
LONG-TERM ASSETS
Property, Plant & Equipment $1.976M $1.935M $1.973M
YoY Change 0.92% 2.65% 7.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $107.0K $99.00K $110.0K
YoY Change -17.69% -15.38% -7.56%
Total Long-Term Assets $5.110M $3.355M $3.648M
YoY Change 64.1% 4.65% 13.15%
TOTAL ASSETS
Total Short-Term Assets $59.33M $62.76M $63.60M
Total Long-Term Assets $5.110M $3.355M $3.648M
Total Assets $64.44M $66.11M $67.25M
YoY Change -8.49% -7.25% 333.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $966.0K $769.0K $847.0K
YoY Change 32.33% -22.48% 69.4%
Accrued Expenses $1.300M $1.187M $998.0K
YoY Change 21.38% 28.46% 18.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.266M $1.956M $1.845M
YoY Change 25.82% 2.09% 38.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $896.0K $956.0K $1.016M
YoY Change -25.89% -24.49% -27.69%
Total Long-Term Liabilities $896.0K $956.0K $1.016M
YoY Change -25.89% -24.49% -27.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.266M $1.956M $1.845M
Total Long-Term Liabilities $896.0K $956.0K $1.016M
Total Liabilities $3.162M $2.912M $2.861M
YoY Change 5.05% -8.49% 4.42%
SHAREHOLDERS EQUITY
Retained Earnings -$98.60M -$96.52M -$95.17M
YoY Change 7.96% 6.93% 6.31%
Common Stock $159.9M $159.7M $159.6M
YoY Change 0.72% 0.86% 55.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $61.28M $63.20M $64.39M
YoY Change
Total Liabilities & Shareholders Equity $64.44M $66.11M $67.25M
YoY Change -8.49% -7.25% 333.52%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$2.078M -$1.347M -$1.604M
YoY Change 95.85% 80.81% 84.79%
Depreciation, Depletion And Amortization $75.00K $74.00K $71.00K
YoY Change 47.06% 64.44% 54.35%
Cash From Operating Activities -$2.891M -$1.422M -$1.313M
YoY Change 158.59% 128.99% 72.76%
INVESTING ACTIVITIES
Capital Expenditures -$123.0K -$26.00K -$81.00K
YoY Change -10.87% -74.0% 35.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$123.0K -$26.00K -$81.00K
YoY Change -10.87% -73.74% 35.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 56.00K
YoY Change -100.0% -100.0% -99.34%
NET CHANGE
Cash From Operating Activities -2.891M -1.422M -1.313M
Cash From Investing Activities -123.0K -26.00K -81.00K
Cash From Financing Activities 0.000 0.000 56.00K
Net Change In Cash -3.014M -1.448M -1.338M
YoY Change 197.53% -102.62% -117.5%
FREE CASH FLOW
Cash From Operating Activities -$2.891M -$1.422M -$1.313M
Capital Expenditures -$123.0K -$26.00K -$81.00K
Free Cash Flow -$2.768M -$1.396M -$1.232M
YoY Change 182.45% 167.95% 76.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
142040266
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
142040266
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
142040266
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141915266
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141915266
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y18D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.72
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.72
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
69
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58904000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63828000 USD
CY2022Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
2140000 USD
CY2021Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
2013000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
1163000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
980000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
551000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
481000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
62758000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
67302000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1935000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1958000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
577000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
768000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000 USD
CY2022Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
562000 USD
CY2021Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
76000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
99000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
130000 USD
CY2022Q1 us-gaap Assets
Assets
66113000 USD
CY2021Q2 us-gaap Assets
Assets
70416000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
769000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
730000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
264000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
252000 USD
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
125000 USD
CY2021Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
98000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
94000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
100000 USD
CY2022Q1 isr Accrued Payroll And Related Taxes Current
AccruedPayrollAndRelatedTaxesCurrent
448000 USD
CY2021Q2 isr Accrued Payroll And Related Taxes Current
AccruedPayrollAndRelatedTaxesCurrent
362000 USD
CY2022Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
256000 USD
CY2021Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
259000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1956000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1801000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
324000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
524000 USD
CY2022Q1 isr Accrued Payroll And Related Taxes Noncurrent
AccruedPayrollAndRelatedTaxesNoncurrent
0 USD
CY2021Q2 isr Accrued Payroll And Related Taxes Noncurrent
AccruedPayrollAndRelatedTaxesNoncurrent
77000 USD
CY2022Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
632000 USD
CY2021Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
608000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
2912000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
3010000 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
142000 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
142000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
159578000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
158589000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-96519000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91325000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
63201000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
67406000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2910000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2600000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8290000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7343000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1469000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1238000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4600000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3568000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1183000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5039000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3379000 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-9000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2817000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2128000 USD
us-gaap Operating Expenses
OperatingExpenses
8975000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1581000 USD
us-gaap Operating Expenses
OperatingExpenses
6128000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1376000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-766000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5285000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
1441000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
1362000 USD
us-gaap Gross Profit
GrossProfit
3690000 USD
us-gaap Gross Profit
GrossProfit
3775000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
549000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
362000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1786000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
959000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
687000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
581000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2150000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1781000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2353000 USD
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
29000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
21000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
91000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
27000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
91000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
27000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1347000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-745000 USD
us-gaap Net Income Loss
NetIncomeLoss
-5194000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2326000 USD
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1347000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-745000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5194000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2329000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142040000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122566000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141970000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91277000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000 USD
us-gaap Net Income Loss
NetIncomeLoss
-5194000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2326000 USD
us-gaap Depreciation
Depreciation
183000 USD
us-gaap Depreciation
Depreciation
107000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-10000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
31000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
28000 USD
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
24000 USD
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
23000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
933000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
260000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
127000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-25000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
669000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
141000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
66000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
57000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
39000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
340000 USD
isr Increase Decrease In Accrued Protocol Expense
IncreaseDecreaseInAccruedProtocolExpense
27000 USD
isr Increase Decrease In Accrued Protocol Expense
IncreaseDecreaseInAccruedProtocolExpense
80000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-6000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
5000 USD
isr Increase Decrease In Accrued Payroll And Related Taxes
IncreaseDecreaseInAccruedPayrollAndRelatedTaxes
9000 USD
isr Increase Decrease In Accrued Payroll And Related Taxes
IncreaseDecreaseInAccruedPayrollAndRelatedTaxes
-109000 USD
isr Increase Decrease In Accrued Vacation
IncreaseDecreaseInAccruedVacation
-3000 USD
isr Increase Decrease In Accrued Vacation
IncreaseDecreaseInAccruedVacation
36000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4819000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1719000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
161000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
266000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-161000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-272000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
-0 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
9000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56375000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
7784000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
56000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
291000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64441000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4924000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
62450000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
64010000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2573000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
59086000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
65023000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58904000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64841000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59086000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65023000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5723000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-713000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5095000 USD
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8471000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
9000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-868000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
12773000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47904000 USD
CY2021Q1 isr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
7784000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
288000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
94000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-745000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
68098000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
67406000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
596000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2243000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
65759000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
180000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1604000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
64391000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
157000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1347000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
63201000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9572000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7553000
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
789000 USD
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
645000 USD
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
355000 USD
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
286000 USD
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
19000 USD
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
49000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
1163000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
980000 USD
CY2022Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
562000 USD
CY2021Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
76000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9366000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9206000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7431000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7248000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1935000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1958000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
3064100
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
165000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.99 pure
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
157000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
94000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
933000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
260000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1113000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6926000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M18D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6926000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y6M18D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4041000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y6M3D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 USD
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
514065
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
652000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
41000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
125000
CY2022Q1 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
0 USD
CY2021Q1 isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
152000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
84075
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
257475
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
234375
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
125000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
520315
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
653000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3064100
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
165000
isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
1763000 USD
isr Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue
170000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
113575
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
4000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
413700
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
237500
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
78000 USD
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
75000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
235000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
227000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06 pure
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
73000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
292000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
264000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
629000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
588000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
264000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
324000 USD

Files In Submission

Name View Source Status
0001437749-22-012202-index-headers.html Edgar Link pending
0001437749-22-012202-index.html Edgar Link pending
0001437749-22-012202.txt Edgar Link pending
0001437749-22-012202-xbrl.zip Edgar Link pending
ex_359721.htm Edgar Link pending
ex_359722.htm Edgar Link pending
ex_359723.htm Edgar Link pending
ex_359724.htm Edgar Link pending
ex_372997.htm Edgar Link pending
ex_372998.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isr-20220331.xsd Edgar Link pending
isr-20220331_cal.xml Edgar Link unprocessable
isr-20220331_def.xml Edgar Link unprocessable
isr-20220331_lab.xml Edgar Link unprocessable
isr-20220331_pre.xml Edgar Link unprocessable
isr20220331_10q.htm Edgar Link pending
isr20220331_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending